New Publication
Homeopathy in Intensive Care
and Emergency Medicine
Homeopathy First Magazine
Best Vitamin C Drink 
Learn More With Caralyn 


Homeopathy World Community

Creating Waves of Awareness

Material Safety Data Sheet for Hepatitis B Nosode 30C

Homeopathic Medicne Hepatitis B Nosode 30c - Material Safety Data Sheets (MSDS) MATERIAL SAFETY DATA SHEET - HOMOEOPATHIC MEDICINE

SECTION I - INFECTIOUS AGENT [ As it is homeopathic medicne . So No Material quantity of Virus is present So it is non Infectious safe and side effect free

NAME: Hepatitis B virus
SYNONYM OR CROSS REFERENCE: Serum hepatitis, type B hepatitis, homologous serum jaundice, Australia antigen hepatitis, HBV, viral hepatitis B, HB

CHARACTERISTICS: Partially double-stranded DNA, 42-47 nm diameter, enveloped, Hepadnaviridae; lipoprotein coat contains the HBsAg


PATHOGENICITY: Two major forms: asymptomatic infection and symptomatic hepatitis; onset is insidious with anorexia, vague abdominal discomfort, nausea and vomiting, sometimes arthralgias and rash, often progressing to jaundice; fever may be absent or mild; severity ranges from inapparent cases to fatal acute hepatic necrosis, or becomes chronically infected; low short term case fatality rate in hospitalized patients; long term case fatality rate is 2-3% due to cancer or cirrhosis of the liver; 95% of adult infections are self limited

EPIDEMIOLOGY: Worldwide; endemic with little seasonal variation; commonly in young adults in North America and in infancy or childhood in Africa and Asia; antigen carrier rate in North America is under 1% for the general population and 10-15% in Asia; common in high risk groups - drug abusers, persons in the health care field exposed to blood or serous fluids, sexually promiscuous individuals

HOST RANGE: Humans (chimpanzees are susceptible)

INFECTIOUS DOSE: Not known, however, 1 mL of infected blood may contain from 102-109 HBV particles

MODE OF TRANSMISSION: Percutaneous or permucosal exposure to infectious body fluids (blood, blood products, cerebral spinal fluid, serum-derived fluids, saliva, semen, vaginal fluids, unfixed tissues and organs), indirect contact with contaminated items in the laboratory; commonly spread by contaminated needles, syringes and other IV equipment; contamination of wounds or lacerations; exposure of mucous membranes; sexual contact, household contact, perinatal transmission from mother to infant, nosocomial exposure

INCUBATION PERIOD: Usually 24-180 days; average 60-90 days; HBsAg can appear in 2 weeks or rarely, 6-9 months, depending on dose, mode of transmission and host factors

COMMUNICABILITY: Blood can be infective weeks before onset of symptoms; remains infective through clinical and chronic carrier states; infectivity of chronically infected individuals varies from highly infectious to sparingly infectious; sera of infected individuals may contain as many as 1010 infectious virons per mL


RESERVOIR: Humans, chimpanzees are susceptible, but an animal reservoir in nature has not been recognized


DRUG SUSCEPTIBILITY: No specific antivirals

SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to many disinfectants; 1% sodium hypochlorite, 70% ethanol, 2% alkalinized glutaraldehyde, formaldehyde

PHYSICAL INACTIVATION: Stable at 37°C for 60 minutes and 56° C for 30 minutes but not at temperatures above 60°C; stable at pH 2.4 for up to 6 hours (some infectivity is lost); HBsAg not destroyed by UV of blood products; stable for years at -70° C

SURVIVAL OUTSIDE HOST: Survives in dried blood for long periods (weeks), stable on environmental surfaces for a least 7 days at 25° C


SURVEILLANCE: Testing of blood samples for the presence of HBsAg, EIA, RIA, PCR

FIRST AID/TREATMENT: Alpha interferon licensed for treatment of chronic infection. About 30% effective in elimination of "e" antigenemia; Lavivudine (reverse transcriptase inhibitor) is being investigated for chronic infections

IMMUNIZATION: Inactivated vaccine is available and recommended for those of increased risk such as laboratory workers and other health care workers exposed to blood

PROPHYLAXIS: Hepatitis B immunoglobulin (HBIG)


LABORATORY-ACQUIRED INFECTIONS: The most frequently occurring laboratory-associated infection; incidence in some categories of laboratory workers is 7 times greater that of the general population; 234 reported cases up to 1974 with one death (3921 total infections surveyed); 26 reported cases in UK laboratories from 1980-1987

SOURCES/SPECIMENS: Blood and blood products, urine, semen, CSF, and saliva

PRIMARY HAZARDS: Parenteral inoculation; droplet exposure of mucous membranes; contact exposure of broken skin

SPECIAL HAZARDS: Needle stick with infected blood


CONTAINMENT REQUIREMENTS: Biosafety level 2 practices and containment for activities utilizing infectious body fluids and tissues; biosafety level 3 primary containment and personnel precautions for activities with high potential for droplet or aerosol production and high production quantities or concentrations; animal biosafety level 2 for work with non-human primates

PROTECTIVE CLOTHING: Laboratory coat; gloves when skin contact is unavoidable and when working with animals; wrap-around gown and gloves for work in biosafety cabinet

OTHER PRECAUTIONS: General needle safety precautions important - do not bend, break or recap the bottles.; dispose directly into puncture-proof container, universal precaution for blood, blood products or specimens containing or contaminated with blood


SPILLS: Allow aerosols to settle; wearing protective clothing, gently cover spill with absorbent paper towel and apply 1% sodium hypochlorite, starting at perimeter and working towards the centre; allow sufficient contact time (30 min) before clean up

DISPOSAL: Decontaminate before disposal; steam sterilization, chemical disinfection, incineration

STORAGE: In sealed containers that are appropriately labelled


Selene Homeopathics 1994 Ltd. Tauranga New Zealand
Meera Shangloo Homeopathic Research Centre Allahabad India

Views: 3689


You need to be a member of Homeopathy World Community to add comments!

Join Homeopathy World Community

Comment by Dr. Aadil Chimthanawala on November 7, 2017 at 2:11am

Which company produces this drug? Has a proving been done? What are the follow-up observations after administering this nosode empirically? 

Comment by Dr.Sharad Shangloo on October 28, 2010 at 1:36am
Actually it a iso Homeopathic treatment. The medicine is prepared by homeopathic method but is given as a Isopathic method. It is not given as an intercurrent remedy. It is given as a main remedy. And it is showing results.
Comment by Debby Bruck on October 20, 2010 at 11:41pm
This you consider isopathic treatment and it can also work.
Comment by Dr.Sharad Shangloo on October 16, 2010 at 1:23am
We are also giving this medicne to Hepatitis B postitive patients . We get the patients HBs Ag test done and check his abscorbance level. After that we give the medicne 2 drops three times a day in 1/2 cup of water and get the test done again the reults are remarkable.You can see the results on
they are supported by Ultrasound and Liver Function test.
Comment by Dr.Sharad Shangloo on October 16, 2010 at 1:15am
Dear Debby Thanks a lot. for the links. But we have to provide the same data to the customs office in India when we import Hepatitis B vac 30c. Homeopathic medicine. This medicine we give to the patients who suffer from the side effects of Hepatitis B vaccination.
Comment by Debby Bruck on October 15, 2010 at 11:19pm
More Links to Information on Hepatitis
Hepatitis B Vaccine is Not Required in India!

Hepatitis B Vaccine - All Don't Need It

Hepatitis-B Vaccine Linked to Brain Damage. Posted by Prof.Dr.Mubashar Ahmad Khan

What is Hepatitis Posted by Dr. Abdul Ghafoor Chughtai

Homeopathy Treats Hepatitis-C

HWC Partners


© 2019   Created by Debby Bruck.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Related Posts Plugin for WordPress, Blogger...